The Andhra Pradesh State Council of Higher Education (APSCHE) has released the AP ECET 2025 Phase 2 counselling schedule.

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

BI 1815368, a potential oral treatment to improve vision in patients with diabetic macular edema, is being investigated in a ...

Imagion Biosystems is on track to start Phase II clinical trial for HER2 breast cancer after a positive meeting with ... Read ...

Kairos Pharma, Ltd. (NYSE American:KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces positive safety results from its ongoing Phase 2 ...

The molecule, developed in collaboration with Massachusetts-based Kailera Therapeutics, is headed for a new drug application ...

After the Grenfell fire there are many lessons to be learned. Architects and manufacturers should be able to demonstrate they ...

In this video, Ashkan M. Abbey, MD, FASRS, FAAO, of Texas Retina Associates, discusses his presentation at Clinical Trials at the Summit on the use of EyePoint’s Duravyu in neovascular age-related ...

Amirco Properties, a real estate company, is expected to break ground on the 4-acre, multi-building development—dubbed ...

The AP ECET 2025 counselling schedule for phase 2 has been issued. This will be the final round of admissions to the second year of Bachelor of Engineering (BE), Bachelor of Technology (BTech), and ...